NYSE:RFL Rafael (RFL) Stock Price, News & Analysis → You won't believe what Citigroup just did to it's depositors (From American Alternative) (Ad) Free RFL Stock Alerts $1.57 -0.02 (-1.26%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$1.54▼$1.6050-Day Range$1.55▼$1.8452-Week Range$1.44▼$2.52Volume20,777 shsAverage Volume20,080 shsMarket Capitalization$38.59 millionP/E Ratio15.70Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Rafael alerts: Email Address Ad Porter & CompanyObama’s Forever Term [exposed]Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here About Rafael Stock (NYSE:RFL)Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More RFL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RFL Stock News HeadlinesMay 29 at 1:48 AM | msn.comRafael Devers’ Red Sox teammate knows slugger won’t ‘shut up’ about tripleMay 29 at 1:48 AM | msn.comRafael Devers (4 hits], Red Sox power up the offense to knock down the OriolesMay 28 at 8:48 PM | msn.comThieves in San Rafael impersonating federal agents, according to policeMay 28 at 8:48 PM | msn.comSan Rafael shooting, car chase injures 1May 28 at 3:47 PM | msn.comRafael Nadal to return to French Open in 2025? Compatriot Alex Corretja reveals chatMay 28 at 3:47 PM | msn.comNeed to clear my head and be ready for Olympics: Rafael NadalMay 28 at 10:47 AM | msn.comIn possible farewell, Rafael Nadal loses in French Open’s first roundMay 28 at 10:47 AM | msn.comDespite recent form, Rafael Nadal's legacy is still gold standard for tennisMay 28 at 10:47 AM | msn.comRafael Nadal says playing Wimbledon is ‘not a good idea’ as he looks to prioritize Paris OlympicsMay 27 at 10:55 PM | abcnews.go.comRafael Nadal loses to Alexander Zverev 6-3, 7-6 (5), 6-3 in the first round of the French OpenMay 27 at 10:55 PM | msn.comRafael Nadal loses in first round of French OpenMay 27 at 5:50 PM | msn.comEven in Defeat, Rafael Nadal Is a Champion at Roland GarrosMay 27 at 5:50 PM | msn.comFrench Open fans get behind ‘super hero’ Rafael NadalMay 27 at 5:50 PM | msn.comRafael Nadal ousted in first round at French Open. Was this his last at Roland Garros?May 27 at 5:50 PM | msn.comRafael Nadal falls to Alexander Zverev in likely final French OpenMay 27 at 5:50 PM | msn.com14-time champion Rafael Nadal loses in the French Open’s first round to Alexander ZverevMay 27 at 5:50 PM | msn.comRafael Nadal’s Son Watches Dad at the 2024 French Open — and He Has His Own Mini Tennis Racket!May 27 at 12:42 PM | msn.comFrench Open 2024: Rafael Nadal beaten by Alexander Zverev in first round on potential Roland Garros farewellMay 27 at 12:42 PM | msn.comRafael Nadal’s possible French Open farewell draws fans from all over the worldMay 27 at 12:42 PM | msn.comRafael Nadal having his 14 French Open titles announced before his opening match will give you goosebumpsMay 27 at 12:42 PM | nytimes.comRafael Nadal loses to Alexander Zverev at Roland GarrosMay 27 at 12:42 PM | msn.comRafael Nadal swept by Alexander Zverev in French Open first roundMay 27 at 12:42 PM | msn.comRafael Nadal suffers French Open first-round heartbreak to controversial rivalMay 27 at 12:42 PM | forbes.comRafael Nadal Falls to Alexander Zverev In What May Have Been His Final Match At Roland GarrosMay 27 at 7:41 AM | msn.comIga Swiatek a clay-court phenomenon to rival Rafael NadalSee More Headlines Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today5/28/2024Next Earnings (Estimated)6/11/2024Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Real estate Sub-IndustryN/A Current SymbolNYSE:RFL CUSIPN/A CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.10 Trailing P/E Ratio15.70 Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,880,000.00 Net Margins776.36% Pretax Margin827.64% Return on Equity-4.31% Return on Assets-4.22% Debt Debt-to-Equity RatioN/A Current Ratio23.01 Quick Ratio23.01 Sales & Book Value Annual Sales$280,000.00 Price / Sales137.82 Cash FlowN/A Price / Cash FlowN/A Book Value$3.98 per share Price / Book0.39Miscellaneous Outstanding Shares24,580,000Free Float22,199,000Market Cap$38.59 million OptionableOptionable Beta1.27 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Howard S. Jonas (Age 68)Founder & Executive Chairman Comp: $40kMr. William Conkling (Age 52)CEO & President Comp: $751.95kMr. David A. Polinsky Esq. (Age 52)Chief Financial Officer Comp: $363.3kMs. Barbara A. Ryan (Age 64)Investor Relations Officer Mr. Gus KodershaChief Technical Operations OfficerDr. Rick EwingHead of Drug DiscoveryDr. John Mayer Goldberg M.D. (Age 51)Chief Medical Officer Ms. Joyce J. Mason Esq. (Age 65)Corporate Secretary More ExecutivesKey CompetitorsOffice Properties Income TrustNASDAQ:OPIMobile InfrastructureNASDAQ:BEEPComstock Holding CompaniesNASDAQ:CHCIreAlpha TechNASDAQ:AIRELuxUrban HotelsNASDAQ:LUXHView All CompetitorsInstitutional OwnershipMarquette Asset Management LLCBought 49,256 shares on 5/7/2024Ownership: 0.200%View All Institutional Transactions RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed in 2024? Rafael's stock was trading at $1.83 at the beginning of the year. Since then, RFL shares have decreased by 14.2% and is now trading at $1.57. View the best growth stocks for 2024 here. Are investors shorting Rafael? Rafael saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 35,600 shares, a drop of 18.7% from the April 30th total of 43,800 shares. Based on an average trading volume of 20,300 shares, the short-interest ratio is currently 1.8 days. View Rafael's Short Interest. When is Rafael's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our RFL earnings forecast. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) announced its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.08) EPS for the quarter. The firm earned $0.07 million during the quarter. Rafael had a net margin of 776.36% and a negative trailing twelve-month return on equity of 4.31%. Who are Rafael's major shareholders? Rafael's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Marquette Asset Management LLC (0.20%). View institutional ownership trends. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RFL) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeHe Is Giving Away BitcoinCrypto Swap ProfitsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.